Rekvina Laboratories Limited

Equities

VINRKLB

INE092O01028

Market Closed - Bombay S.E. 05:00:54 2021-12-13 EST 5-day change 1st Jan Change
4.5 INR -.--% Intraday chart for Rekvina Laboratories Limited -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary CI
Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Rekvina Laboratories Limited Appoints Pravin Chauhan as the Chief Financial Officer CI
Rekvina Laboratories Limited Announces Management Changes CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Rekvina Laboratories Trims Net Loss in Fiscal Q4 MT
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Rekvina Laboratories Limited Appoints Bhavesh Prabhudas Vora as Non ­ Executive, Additional Independent Director CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2019 CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018 CI
Rekvina Laboratories Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
Rekvina Laboratories Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018 CI
  1. Stock Market
  2. Equities
  3. VINRKLB Stock
  4. News Rekvina Laboratories Limited
  5. Rekvina Laboratories Trims Net Loss in Fiscal Q4